Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

Detalles Bibliográficos
Autores principales: Ohlmann, Carsten-Henning, Jäschke, Michelle, Jaehnig, Peter, Krege, Susanne, Gschwend, Jürgen, Rexer, Heidrun, Junker, Kerstin, Zillmann, Roger, Rüssel, Christoph, Hellmis, Eva, Suttmann, Henrik, Janssen, Martin, Marin, Jan, Hübner, Andreas, Mathers, Michael, Gleißner, Jochen, Scheffler, Michael, Feyerabend, Susan, Telle, Jens, Klier, Jörg, Stöckle, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638078/
https://www.ncbi.nlm.nih.gov/pubmed/37253975
http://dx.doi.org/10.1038/s41391-023-00682-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638078/
https://www.ncbi.nlm.nih.gov/pubmed/37253975
http://dx.doi.org/10.1038/s41391-023-00682-2

Ejemplares similares